Skip to Content

Nutra Pharma Corp NPHC Stock Quote

| Rating as of


Last close prices updated as of Jun 02, 2023, 10:47 AM EST | USD
  • Last Close < 0.01
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style
  • Day Range < 0.01  –  < 0.01
  • Year Range < 0.01  –  < 0.01
  • Market Cap 759,685.2214
  • Volume / Avg 150.0 /  237,973.6
  • Price / Sales 5.31
  • Price / Book
  • Forward Div Yield 4.38%
  • Trailing Div Yield

Morningstar‘s Stock Analysis NPHC

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics NPHC

Company Profile NPHC

Business Description

Nutra Pharma Corp operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. It also develops proprietary therapeutic protein products primarily for the prevention and treatment of viral and neurological diseases, including Multiple Sclerosis (MS), Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), and pain in humans. Some of its drug names are Cobroxin, Nyloxin, RPI-78M, RPI-MN and Pet Pain-Away.

1537 NW 65th Avenue
Plantation, FL, 33313
Industry Drug Manufacturers - Specialty & Generic
Employees 5

Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.

Nutra Pharma Corp


Rigel Pharmaceuticals Inc


Adamas Pharmaceuticals Inc


Enanta Pharmaceuticals Inc

$0.00 (0.00%) −$0.04 (2.56%) +$0.72 (2.92%)
Market Cap
759,685.22236.92 Mil536.33 Mil
Drug Manufacturers - Specialty & Generic Biotechnology Drug Manufacturers - Specialty & Generic Biotechnology

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Nutra Pharma Corp Stock

No. NPHC does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

NPHC’s market cap is 759,685.22.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

NPHC’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

NPHC’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare NPHC’s historical performance against its industry peers and the overall market.